Skip to main content
Top
Published in: Abdominal Radiology 6/2017

Open Access 01-06-2017

Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?

Authors: Miriam M. van Heeswijk, Doenja M. J. Lambregts, Monique Maas, Max J. Lahaye, Z. Ayas, Jos M. G. M. Slenter, Geerard L. Beets, Frans C. H. Bakers, Regina G. H. Beets-Tan

Published in: Abdominal Radiology | Issue 6/2017

Login to get access

Abstract

Purpose

The apparent diffusion coefficient (ADC) is a potential prognostic imaging marker in rectal cancer. Typically, mean ADC values are used, derived from precise manual whole-volume tumor delineations by experts. The aim was first to explore whether non-precise circular delineation combined with histogram analysis can be a less cumbersome alternative to acquire similar ADC measurements and second to explore whether histogram analyses provide additional prognostic information.

Methods

Thirty-seven patients who underwent a primary staging MRI including diffusion-weighted imaging (DWI; b0, 25, 50, 100, 500, 1000; 1.5 T) were included. Volumes-of-interest (VOIs) were drawn on b1000-DWI: (a) precise delineation, manually tracing tumor boundaries (2 expert readers), and (b) non-precise delineation, drawing circular VOIs with a wide margin around the tumor (2 non-experts). Mean ADC and histogram metrics (mean, min, max, median, SD, skewness, kurtosis, 5th–95th percentiles) were derived from the VOIs and delineation time was recorded. Measurements were compared between the two methods and correlated with prognostic outcome parameters.

Results

Median delineation time reduced from 47–165 s (precise) to 21–43 s (non-precise). The 45th percentile of the non-precise delineation showed the best correlation with the mean ADC from the precise delineation as the reference standard (ICC 0.71–0.75). None of the mean ADC or histogram parameters showed significant prognostic value; only the total tumor volume (VOI) was significantly larger in patients with positive clinical N stage and mesorectal fascia involvement.

Conclusion

When performing non-precise tumor delineation, histogram analysis (in specific 45th ADC percentile) may be used as an alternative to obtain similar ADC values as with precise whole tumor delineation. Histogram analyses are not beneficial to obtain additional prognostic information.
Literature
1.
go back to reference Curvo-Semedo L, Lambregts DM, Maas M, et al. (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy–conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260(3):734–743CrossRefPubMed Curvo-Semedo L, Lambregts DM, Maas M, et al. (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy–conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260(3):734–743CrossRefPubMed
2.
go back to reference Lambregts DM, Vandecaveye V, Barbaro B, et al. (2011) Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 18(8):2224–2231CrossRefPubMedPubMedCentral Lambregts DM, Vandecaveye V, Barbaro B, et al. (2011) Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 18(8):2224–2231CrossRefPubMedPubMedCentral
3.
go back to reference Kim SH, Lee JM, Hong SH, et al. (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 253(1):116–125CrossRefPubMed Kim SH, Lee JM, Hong SH, et al. (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 253(1):116–125CrossRefPubMed
4.
go back to reference van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S (2013) Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 269(1):101–112CrossRefPubMed van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S (2013) Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 269(1):101–112CrossRefPubMed
5.
go back to reference Curvo-Semedo L, Lambregts DM, Maas M, et al. (2012) Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 35(6):1365–1371CrossRefPubMed Curvo-Semedo L, Lambregts DM, Maas M, et al. (2012) Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 35(6):1365–1371CrossRefPubMed
6.
go back to reference Sun Y, Tong T, Cai S, et al. (2014) Apparent diffusion coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer. PLoS ONE 9(10):e109371CrossRefPubMedPubMedCentral Sun Y, Tong T, Cai S, et al. (2014) Apparent diffusion coefficient (ADC) value: a potential imaging biomarker that reflects the biological features of rectal cancer. PLoS ONE 9(10):e109371CrossRefPubMedPubMedCentral
7.
go back to reference Akashi M, Nakahusa Y, Yakabe T, et al. (2014) Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors. Acta Radiol. 55(5):524–531CrossRefPubMed Akashi M, Nakahusa Y, Yakabe T, et al. (2014) Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors. Acta Radiol. 55(5):524–531CrossRefPubMed
8.
go back to reference Tong T, Yao Z, Xu L, et al. (2014) Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value. J Magn Reson Imaging. 40(3):738–744CrossRefPubMed Tong T, Yao Z, Xu L, et al. (2014) Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value. J Magn Reson Imaging. 40(3):738–744CrossRefPubMed
9.
go back to reference Cho SH, Kim GC, Jang YJ, et al. (2015) Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response. Acta Radiol. 56(9):1042–1050CrossRefPubMed Cho SH, Kim GC, Jang YJ, et al. (2015) Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response. Acta Radiol. 56(9):1042–1050CrossRefPubMed
10.
go back to reference Choi MH, Oh SN, Rha SE, et al. (2016) Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging. 44(1):212–220CrossRefPubMed Choi MH, Oh SN, Rha SE, et al. (2016) Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging. 44(1):212–220CrossRefPubMed
11.
go back to reference Barbaro B, Vitale R, Valentini V, et al. (2012) Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 83(2):594–599CrossRefPubMed Barbaro B, Vitale R, Valentini V, et al. (2012) Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 83(2):594–599CrossRefPubMed
12.
go back to reference Sun YS, Zhang XP, Tang L, et al. (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 254(1):170–178CrossRefPubMed Sun YS, Zhang XP, Tang L, et al. (2010) Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology. 254(1):170–178CrossRefPubMed
13.
go back to reference Intven M, Reerink O, Philippens ME (2013) Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol. 189(2):117–122CrossRefPubMed Intven M, Reerink O, Philippens ME (2013) Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol. 189(2):117–122CrossRefPubMed
14.
go back to reference Dzik-Jurasz A, Domenig C, George M, et al. (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 360(9329):307–308CrossRefPubMed Dzik-Jurasz A, Domenig C, George M, et al. (2002) Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 360(9329):307–308CrossRefPubMed
15.
go back to reference Kremser C, Judmaier W, Hein P, et al. (2003) Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol. 179(9):641–649CrossRefPubMed Kremser C, Judmaier W, Hein P, et al. (2003) Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol. 179(9):641–649CrossRefPubMed
16.
go back to reference Kim SH, Lee JY, Lee JM, Han JK, Choi BI (2011) Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol. 21(5):987–995CrossRefPubMed Kim SH, Lee JY, Lee JM, Han JK, Choi BI (2011) Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol. 21(5):987–995CrossRefPubMed
17.
go back to reference Roth Y, Tichler T, Kostenich G, et al. (2004) High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology. 232(3):685–692CrossRefPubMed Roth Y, Tichler T, Kostenich G, et al. (2004) High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology. 232(3):685–692CrossRefPubMed
18.
go back to reference Lambregts DM, Beets GL, Maas M, et al. (2011) Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 21(12):2567–2574CrossRefPubMedPubMedCentral Lambregts DM, Beets GL, Maas M, et al. (2011) Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 21(12):2567–2574CrossRefPubMedPubMedCentral
19.
go back to reference Nougaret S, Vargas HA, Lakhman Y, et al. (2016) Intravoxel incoherent motion-derived histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer: initial experience and comparison between single-section and volumetric analyses. Radiology 280(2):446–454CrossRefPubMed Nougaret S, Vargas HA, Lakhman Y, et al. (2016) Intravoxel incoherent motion-derived histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer: initial experience and comparison between single-section and volumetric analyses. Radiology 280(2):446–454CrossRefPubMed
20.
go back to reference Mandard AM, Dalibard F, Mandard JC, et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11):2680–2686CrossRefPubMed Mandard AM, Dalibard F, Mandard JC, et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11):2680–2686CrossRefPubMed
21.
go back to reference Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat. 6:65–70 Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat. 6:65–70
22.
go back to reference van Heeswijk MM, Lambregts DM, van Griethuysen JJ, et al. (2016) Automated and semiautomated segmentation of rectal tumor volumes on diffusion-weighted MRI: can it replace manual volumetry? Int J Radiat Oncol Biol Phys. 94(4):824–831CrossRefPubMed van Heeswijk MM, Lambregts DM, van Griethuysen JJ, et al. (2016) Automated and semiautomated segmentation of rectal tumor volumes on diffusion-weighted MRI: can it replace manual volumetry? Int J Radiat Oncol Biol Phys. 94(4):824–831CrossRefPubMed
23.
go back to reference Jung SH, Heo SH, Kim JW, et al. (2012) Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging. 35(1):110–116CrossRefPubMed Jung SH, Heo SH, Kim JW, et al. (2012) Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging. 35(1):110–116CrossRefPubMed
24.
go back to reference Lambrecht M, Deroose C, Roels S, et al. (2010) The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol. 49(7):956–963CrossRefPubMed Lambrecht M, Deroose C, Roels S, et al. (2010) The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. Acta Oncol. 49(7):956–963CrossRefPubMed
25.
go back to reference Lambrecht M, Vandecaveye V, De Keyzer F, et al. (2012) Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 82(2):863–870CrossRefPubMed Lambrecht M, Vandecaveye V, De Keyzer F, et al. (2012) Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 82(2):863–870CrossRefPubMed
26.
go back to reference DeVries AF, Kremser C, Hein PA, et al. (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys. 56(4):958–965CrossRefPubMed DeVries AF, Kremser C, Hein PA, et al. (2003) Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys. 56(4):958–965CrossRefPubMed
27.
go back to reference Ippolito D, Monguzzi L, Guerra L, et al. (2012) Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging. 37(6):1032–1040CrossRefPubMed Ippolito D, Monguzzi L, Guerra L, et al. (2012) Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging. 37(6):1032–1040CrossRefPubMed
28.
go back to reference Kim YC, Lim JS, Keum KC, et al. (2011) Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging. 34(3):570–576CrossRefPubMed Kim YC, Lim JS, Keum KC, et al. (2011) Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging. 34(3):570–576CrossRefPubMed
29.
go back to reference Monguzzi L, Ippolito D, Bernasconi DP, et al. (2013) Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol. 82(2):234–240CrossRefPubMed Monguzzi L, Ippolito D, Bernasconi DP, et al. (2013) Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol. 82(2):234–240CrossRefPubMed
30.
go back to reference Lambregts DM, Rao SX, Sassen S, et al. (2015) MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg. 262(6):1034–1039CrossRefPubMed Lambregts DM, Rao SX, Sassen S, et al. (2015) MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg. 262(6):1034–1039CrossRefPubMed
Metadata
Title
Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?
Authors
Miriam M. van Heeswijk
Doenja M. J. Lambregts
Monique Maas
Max J. Lahaye
Z. Ayas
Jos M. G. M. Slenter
Geerard L. Beets
Frans C. H. Bakers
Regina G. H. Beets-Tan
Publication date
01-06-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1062-2

Other articles of this Issue 6/2017

Abdominal Radiology 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.